Daniel Meruelo相关文献与解析，生知库 | 链接生命科学的每一步

Combination of a Sindbis-SARS-CoV-2 Spike Vaccine and αOX40 Antibody Elicits Protective Immunity Against SARS-CoV-2 Induced Disease and Potentiates Long-Term SARS-CoV-2-Specific Humoral and T-Cell Immunity

Sindbis-SARS-CoV-2 刺突疫苗与 αOX40 抗体联合使用可引发针对 SARS-CoV-2 诱发疾病的保护性免疫，并增强长期 SARS-CoV-2 特异性体液和 T 细胞免疫

doi:10.3389/fimmu.2021.719077

Antonella Scaglione, Silvana Opp, Alicia Hurtado, Ziyan Lin, Christine Pampeno, Maria G Noval, Sara A Thannickal, Kenneth A Stapleford, Daniel Meruelo

Combination of a Sindbis-SARS-CoV-2 spike vaccine and αOX40 antibody elicits protective immunity against SARS-CoV-2 induced disease and potentiates long-term SARS-CoV-2-specific humoral and T-cell immunity

Sindbis-SARS-CoV-2 刺突疫苗与 αOX40 抗体的结合可引发针对 SARS-CoV-2 诱发疾病的保护性免疫，并增强长期 SARS-CoV-2 特异性体液和 T 细胞免疫

期刊:

影响因子:

doi:10.1101/2021.05.28.446009

Antonella Scaglione, Silvana Opp, Alicia Hurtado, Ziyan Lin, Christine Pampeno, Maria G Noval, Sara A Thannickal, Kenneth A Stapleford, Daniel Meruelo

Sindbis Virus with Anti-OX40 Overcomes the Immunosuppressive Tumor Microenvironment of Low-Immunogenic Tumors

具有抗 OX40 的辛德毕斯病毒可克服低免疫原性肿瘤的免疫抑制肿瘤微环境

期刊:Molecular Therapy-Oncolytics

影响因子:5.3

doi:10.1016/j.omto.2020.04.012

Iris Scherwitzl, Silvana Opp, Alicia M Hurtado, Christine Pampeno, Cynthia Loomis, Kasthuri Kannan, Minjun Yu, Daniel Meruelo

Molecular and metabolic pathways mediating curative treatment of a non-Hodgkin B cell lymphoma by Sindbis viral vectors and anti-4-1BB monoclonal antibody

介导辛德毕斯病毒载体和抗 4-1BB 单克隆抗体治愈非霍奇金 B 细胞淋巴瘤的分子和代谢途径

期刊:Journal for ImmunoTherapy of Cancer

影响因子:10.3

doi:10.1186/s40425-019-0664-3

Minjun Yu, Iris Scherwitzl, Silvana Opp, Aristotelis Tsirigos, Daniel Meruelo

Functional/Block/Neutralize

The Transition of the 37-Kda Laminin Receptor (Rpsa) to Higher Molecular Weight Species: Sumoylation or Artifact?

37-Kda 层粘连蛋白受体 (Rpsa) 向更高分子量物种的转变：SUMO 化还是人工产物？

期刊:Cellular & Molecular Biology Letters

影响因子:9.2

doi:10.1515/cmble-2015-0031

Vincent Digiacomo, Ivan A Gando, Lisa Venticinque, Alicia Hurtado, Daniel Meruelo

信号转导

发表日期：2015

文献求助收藏

Sindbis viral vectors transiently deliver tumor-associated antigens to lymph nodes and elicit diversified antitumor CD8+ T-cell immunity

Sindbis 病毒载体暂时将肿瘤相关抗原递送至淋巴结并引发多样化的抗肿瘤 CD8+ T 细胞免疫

期刊:Molecular Therapy

影响因子:12.1

doi:10.1038/mt.2013.215

Tomer Granot, Yoshihide Yamanashi, Daniel Meruelo

TBLR1 as an androgen receptor (AR) coactivator selectively activates AR target genes to inhibit prostate cancer growth

TBLR1 作为雄激素受体 (AR) 辅激活因子选择性激活 AR 靶基因以抑制前列腺癌生长

期刊:Endocrine-Related Cancer

影响因子:4.1

doi:10.1530/ERC-13-0293

Garrett Daniels, Yirong Li, Lan Lin Gellert, Albert Zhou, Jonathan Melamed, Xinyu Wu, Xinming Zhang, David Zhang, Daniel Meruelo, Susan K Logan, Ross Basch, Peng Lee

Interaction of human laminin receptor with Sup35, the [PSI⁺] prion-forming protein from S. cerevisiae: a yeast model for studies of LamR interactions with amyloidogenic proteins

人类层粘连蛋白受体与 Sup35（来自酿酒酵母的 [PSI⁺] 朊病毒形成蛋白）的相互作用：用于研究 LamR 与淀粉样蛋白相互作用的酵母模型

期刊:PLoS One

影响因子:2.9

doi:10.1371/journal.pone.0086013

Christine Pampeno, Irina L Derkatch, Daniel Meruelo

ATM kinase is activated by sindbis viral vector infection

ATM 激酶被辛德毕斯病毒载体感染激活

期刊:Virus Research

影响因子:2.5

doi:10.1016/j.virusres.2012.03.008

Christine Pampeno, Alicia Hurtado, Daniel Meruelo

Potent and Targeted Sindbis Virus Platform for Immunotherapy of Ovarian Cancer

用于卵巢癌免疫治疗的高效靶向辛德毕斯病毒平台

Combination of a Sindbis-SARS-CoV-2 Spike Vaccine and αOX40 Antibody Elicits Protective Immunity Against SARS-CoV-2 Induced Disease and Potentiates Long-Term SARS-CoV-2-Specific Humoral and T-Cell Immunity

Sindbis-SARS-CoV-2 刺突疫苗与 αOX40 抗体联合使用可引发针对 SARS-CoV-2 诱发疾病的保护性免疫，并增强长期 SARS-CoV-2 特异性体液和 T 细胞免疫

Combination of a Sindbis-SARS-CoV-2 spike vaccine and αOX40 antibody elicits protective immunity against SARS-CoV-2 induced disease and potentiates long-term SARS-CoV-2-specific humoral and T-cell immunity

Sindbis-SARS-CoV-2 刺突疫苗与 αOX40 抗体的结合可引发针对 SARS-CoV-2 诱发疾病的保护性免疫，并增强长期 SARS-CoV-2 特异性体液和 T 细胞免疫

Sindbis Virus with Anti-OX40 Overcomes the Immunosuppressive Tumor Microenvironment of Low-Immunogenic Tumors

具有抗 OX40 的辛德毕斯病毒可克服低免疫原性肿瘤的免疫抑制肿瘤微环境

Molecular and metabolic pathways mediating curative treatment of a non-Hodgkin B cell lymphoma by Sindbis viral vectors and anti-4-1BB monoclonal antibody

介导辛德毕斯病毒载体和抗 4-1BB 单克隆抗体治愈非霍奇金 B 细胞淋巴瘤的分子和代谢途径

The Transition of the 37-Kda Laminin Receptor (Rpsa) to Higher Molecular Weight Species: Sumoylation or Artifact?

37-Kda 层粘连蛋白受体 (Rpsa) 向更高分子量物种的转变：SUMO 化还是人工产物？

Sindbis viral vectors transiently deliver tumor-associated antigens to lymph nodes and elicit diversified antitumor CD8+ T-cell immunity

Sindbis 病毒载体暂时将肿瘤相关抗原递送至淋巴结并引发多样化的抗肿瘤 CD8+ T 细胞免疫

TBLR1 as an androgen receptor (AR) coactivator selectively activates AR target genes to inhibit prostate cancer growth

TBLR1 作为雄激素受体 (AR) 辅激活因子选择性激活 AR 靶基因以抑制前列腺癌生长

Interaction of human laminin receptor with Sup35, the [PSI⁺] prion-forming protein from S. cerevisiae: a yeast model for studies of LamR interactions with amyloidogenic proteins

人类层粘连蛋白受体与 Sup35（来自酿酒酵母的 [PSI⁺] 朊病毒形成蛋白）的相互作用：用于研究 LamR 与淀粉样蛋白相互作用的酵母模型

ATM kinase is activated by sindbis viral vector infection

ATM 激酶被辛德毕斯病毒载体感染激活